RBC Capital Markets

Well Care Health CEO: We’re Pushing the Envelope of Care Innovation | 9/13/2019

… announcement of its $340 million Compassionate Care Hospice deal in October 2018. “We are really going to feed the beast in hospice,” Amedisys CEO and President Paul Kusserow said during a presentation at the RBC Capital Markets Global Healthcare Conference in May. “Right now from an M&A perspective — where we should be focusing on de novos, on tuck-ins, on deals, on integrations — we are pushing hospice.” Generally, there …

Empire Company Limited (EMLAF) CEO Michael Medline on Q1 2020 Results - Earnings Call Transcript | Seeking Alpha | 9/13/2019

Empire Company Limited ( OTCPK:EMLAF ) Q1 2020 Earnings Conference Call September 12, 2019 1:00 PM ET Company Participants Katie Brine - Director, IR Michael Medline - President and CEO Michael Vels - CFO Pierre St Laurent - EVP, Merchandising and Quebec Conference Call Participants Karen Short - Barclays Capital Vishal Shreedhar - National Bank Financial, Inc. Irene Nattel - RBC Capital Markets, LLC Michael Van Aelst - TD Securities Patricia Baker - Scotiabank Global Banking and Markets Peter Sklar …

Follow RBC Capital Markets:    

Encompass Health announces launch of senior notes offering | PR Newswire | 9/9/2019

BIRMINGHAM, Ala. , Sept. 9, Encompass Health Corporation (NYSE: EHC ) today announced it has commenced a public offering of $800 million in aggregate principal amount of senior notes. The notes are to be issued in two series, one maturing in 2028 and the other in 2030. The Company intends to use the net proceeds from this offering to fund the purchase of equity from management investors of its home health and …

Addus HomeCare Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares | PR Newswire | 9/9/2019

FRISCO, Texas , Sept. 9, Addus HomeCare Corporation (Nasdaq: ADUS ) (“Addus” or the “Company”), a provider of comprehensive home care services, today announced the closing of an underwritten public offering of 2,300,000 shares of its common stock (“Common Stock”), including 300,000 shares of Common Stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares, at a public offering price of $79.50 per share …

Broker Forecast - RBC Capital Markets issues a broker note on Spire Healthcare Group | 9 September 2019 | Stock Market Wire | 9/9/2019

RBC Capital Markets today initiates coverage of Spire Healthcare Group [ LON:SPI ] with a outperform investment rating and price target of 149p. Broker Forecasts data provided by www.sharesmagazine.co.uk …

Murphy USA Inc. Announces Launch of Notes Offering | Globe Newswire | 9/4/2019

September 04, 2019 07:30 ET Source: Murphy USA Inc. EL DORADO, Ark., Sept. 04, 2019 (GLOBE NEWSWIRE) – Murphy USA Inc. (“Murphy USA”) (NYSE: MUSA) announced today the planned offering of $500 million aggregate principal amount of senior notes due 2029 (the “Notes”) by its wholly owned subsidiary, Murphy Oil USA, Inc. (“Murphy Oil USA”), subject to market and other conditions. The Notes will be guaranteed on a senior unsecured basis …

KemPharm Announces Entry into Definitive Collaboration and License Agreement for its ADHD Candidates, KP415 and KP484, with an Affiliate of Gurnet Point Capital | Globe Newswire | 9/4/2019

… approved. In addition, we are impressed by KemPharm’s prodrug discovery and development capabilities, and we look forward to the potential to collaborate with the KemPharm team on other pipeline product candidates in the future.” RBC Capital Markets served as KemPharm’s exclusive financial advisor. KemPharm Enters into Debt Exchange Agreement and Other Amendments to its Senior Debt Facility with Deerfield: Contemporaneous with execution of the License Agreement, KemPharm also entered into …

Selecta Biosciences Appoints Brad Dahms as Chief Financial Officer | Globe Newswire | 9/4/2019

September 04, 2019 08:00 ET Source: Selecta Biosciences, Inc. WATERTOWN, Mass., Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune tolerance platform technology, ImmTOR™, today announced the appointment of Brad Dahms as Chief Financial Officer. “Brad has deep financial and capital markets expertise within the biotech sector as a result of his tenure as a life …

Murphy USA Inc. Announces Launch of Notes Offering … | MarketWatch | 9/4/2019

EL DORADO, Ark., Sep 04, 2019 (GLOBE NEWSWIRE via COMTEX) – EL DORADO, Ark., Sept. 04, 2019 (GLOBE NEWSWIRE) – Murphy USA Inc. (“Murphy USA”) MUSA, -2.30% announced today the planned offering of $500 million aggregate principal amount of senior notes due 2029 (the “Notes”) by its wholly owned subsidiary, Murphy Oil USA, Inc. (“Murphy Oil USA”), subject to market and other conditions. The Notes will be guaranteed on a senior unsecured …

Selecta BiosciencesAppoints Brad Dahms as Chief Financial Officer | Financial Buzz | 9/4/2019

WATERTOWN, Mass., Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune tolerance platform technology, ImmTOR™, today announced the appointment of Brad Dahms as Chief Financial Officer. “Brad has deep financial and capital markets expertise within the biotech sector as a result of his tenure as a life sciences investment banker. We are thrilled to have him …

FAANG Stocks Have Evolved – And Now They’re Inexpensive - TheStreet | 9/3/2019

… an attractive entry point, considering what’s on the agenda for these names? Netflix’s new growth market in the EU and Asia is looking strong. Even though it missed subscriber estimates in its latest quarter, RBC Capital Markets analyst Mark Mahaney wrote in a note out last week, Netflix is seeing positive subscriber addition trends in the EU, especially the United Kingdom, which sported an 80% satisfaction rate, which points to …

Addus HomeCare Announces Public Offering of Common Stock | PR Newswire | 9/3/2019

FRISCO, Texas , Sept. 3, 2019 /PRNewswire/ – Addus HomeCare Corporation (Nasdaq: ADUS ) (“Addus” or the “Company”), a provider of comprehensive home care services, today announced that it has commenced a proposed public offering of 2,000,000 shares of its common stock. In addition, funds affiliated with Eos Partners (the “Selling Stockholders”) intend to offer 500,000 shares. Addus expects to grant the underwriters a 30-day option to purchase up to 300,000 additional …

Kilroy Realty, L.P. Prices $500.0 Million of 3.050% Senior Notes Due 2030 | Business Wire | 9/3/2019

LOS ANGELES- Kilroy Realty Corporation (NYSE:KRC) (the “Company”) today announced that its operating partnership, Kilroy Realty, L.P., has priced an underwritten public offering of $500.0 million aggregate principal amount of its 3.050% senior notes due 2030 (the “Notes”). The Notes will pay interest at the rate of 3.050% per annum payable semi-annually in arrears on February 15 th and August 15 th of each year, commencing February 15 …

CMS updates Medicare Plan Finder following stakeholder pressure | Healthcare Dive | 8/27/2019

CMS updates Medicare Plan Finder following stakeholder pressure CMS share Dive Brief: CMS is updating its online comparison shopping tool for Medicare coverage, including Medicare Advantage and Part D plans, for the first time in a decade, responding to criticism from stakeholders that call it difficult to use and incomplete. Using the new Medicare Plan Finder, beneficiaries can now compare pricing between different plans on desktop, smartphone or tablet, directly …

Celgene to sell psoriasis drug Otezla for $13.4 billion to Amgen | Yahoo News | 8/26/2019

File photo of an Amgen sign at the company’s office in South San Francisco More (Reuters) - Amgen Inc said on Monday it would buy Celgene Corp’s psoriasis drug Otezla for $13.4 billion in cash, clearing the way for Bristol-Myers Squibb to go ahead with its $74 billion deal for Celgene. Bristol-Myers now expects the Celgene deal to close by 2019 end, pushing Celgene’s shares up 3% before the …

Amgen to buy Celgene’s psoriasis drug Otezla for $13.4 billion in cash | Yahoo News | 8/26/2019

Bristol-Myers now expects the Celgene deal to close by 2019 end, pushing Celgene’s shares up 3% before the opening bell. Amgen shares, however, fell as some investors worried that the company was shelling out more-than-expected for the drug.” data-reactid=”23” Bristol-Myers now expects the Celgene deal to close by 2019 end, pushing Celgene’s shares up 3% before the opening bell. Amgen shares, however, fell as …

Amgen, maker of Enbrel, to pick up Celgene’s Otezla for $13.4B. Will FTC hit back? | FiercePharma | 8/26/2019

Looks like Amgen might not be buying Alexion Pharmaceuticals after all. Instead, it’s beefing up in psoriasis, where it already sells blockbuster TNF inhibitor Enbrel. Amgen Monday said it will take in Celgene’s Otezla for $13.4 billion in cash, a purchase that could help Bristol-Myers Squibb move along with its planned acquisition of Celgene for $74 billion, per an agreement with U.S. antitrust authorities. The dollar amount easily dwarfs …

Our First LIHTC Investment in Indian Country | 8/26/2019

… Low-Income Housing Tax Credit (LIHTC) investment on tribal land. Freddie Mac Multifamily’s $9.4 million investment of LIHTC equity will help build 35 rental homes on Yavapai-Apache Nation land — through a partnership with RBC Capital Markets (RBCCM) and the Yavapai-Apache Nation Tribal Housing group (YANTH). The ranch-style homes and duplexes, three- and four-bedroom, will help ease the burden for families waiting for housing. “The Yavapai-Apache …

Not so fast, Endo and Allergan: Ohio’s AG is looking past your opioid deals | FiercePharma | 8/23/2019

With national opioid litigation heating up, Endo and Allergan saw an off-ramp and took it, agreeing to settle with two Ohio counties for a combined $16 million this week. But the state’s attorney general has a message for the drugmakers: You’re not off the hook yet. The state of Ohio plans to fully prosecute Endo and Allergan despite their county-level settlements, AG Dave Yost said in two letters …

Broader Market Drags Affecting Salesforce Could Drive Buying Opportunity - RealMoney | TheStreet | 8/23/2019

CRM shouldn’t be sagging with the broader tech sector. Stocks quotes in this article: CRM , ORCL , MSFT , GOOGL Salesforce ( CRM ) is seeing its gains eroded by the macro factors moving tech sectors lower on Friday, but that could be a positive for those looking for options as trade fears mount. Shares of the San Francisco-based cloud king jumped to start the day , rising over 6% on the open after …

AMA

Pivotal Software, Inc. (PVTL) CEO Robert Mee on Q1 2020 Results - Earnings Call Transcript | Seeking Alpha | 6/5/2019

… build a new online-banking platform. What started as a Labs project quickly expanded to the company implementing PAS on Amazon Web Services. It took the joint team less than five weeks to deliver a … next question comes from the line of Matt Hedberg from RBC Capital Markets. Your line is open. Unidentified Analyst Hey, it’s Dan [ph] for Matt Hedberg. Thanks for taking my questions. Say to build off …

IPO Update: Chewy Prepares For $749 Million IPO - Chewy (Pending:CHWY) | Seeking Alpha | 6/4/2019

… and Director Sumit Singh , who has been with the firm since 2017 and was previously general manager and director of Amazon’s ( AMZN ) North American Merchant Fulfillment and Third-party operations. Chewy has a selection of … Morgan Stanley, J.P. Morgan, Allen & Co., BofA Merrill Lynch, Barclays, RBC Capital Markets, UBS Investment Bank, Nomura, Raymond James, Jefferies, Wells Fargo Securities, and William Blair. Commentary I previously wrote about Chewy’s IPO prospects in …

ACO

Ag Growth International, Inc. (AGGZF) CEO Tim Close on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/10/2019

Ag Growth International, Inc. ( OTCPK:AGGZF ) Q2 2019 Earnings Conference Call August 8, 2019 8:00 AM ET Company Participants Tim Close - President, CEO & Director Steve Sommerfeld - EVP, CFO & Corporate Secretary Conference Call Participants Jacob Bout - CIBC Capital Markets Michael Doumet - Scotiabank David Newman - Desjardins Securities Andrew Wong - RBC Capital Markets Greg Colman - National Bank Financial Steven Hansen - Raymond James Ltd. Operator Good morning. My name is Jessica, and I will …

Perrigo Company’s (PRGO) CEO Murray Kessler on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/8/2019

… President-Investor Relations Murray Kessler – President and Chief Executive Officer Ray Silcock – Chief Financial Officer Conference Call Participants Randall Stanicky – RBC Capital Markets Louise Chen – Cantor Fitzgerald Greg Fraser – SunTrust David Maris – Wells Fargo David … launch of XLS Forte 5 and strong performance by the ACO brand. New products yielded $65 million in consolidated net sales during the quarter. Third, we closed on the divestiture of the Animal Health business …

ACA

Form 8.5 (EPT/NON-RI) Acacia Mining – Company Announcement - FT.com | Financial Times | 8/20/2019

RNS Number : 6736J RBC Capital Markets 20 August 2019 FORM 8.5 (EPT/NON-RI) PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (“RI”) STATUS (OR WHERE RI STATUS IS … form relates: Use a separate form for each offeror/offeree Acacia Mining (ACA:LN) (c) Name of the party to the offer with which exempt principal trader is connected: Offeree Concert Party (d) Date position

Wolfe Research

WESCO International, Inc. (WCC) CEO John Engel on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/5/2019

WESCO International, Inc. (NYSE: WCC ) Q2 2019 Results Earnings Conference Call August 1, 2019 10:00 AM ET Company Participants Will Ruthrauff - Director of Investor Relations John Engel - Chairman, President, Chief Executive Officer Dave Schulz - Senior Vice President, Chief Financial Officer Conference Call Participants Deane Dray - RBC Capital Markets David Manthey - Baird Sam Darkatsh - Raymond James Robert Barry - Buckingham Research Ryan Mills - KeyBanc Capital Markets Nigel Coe - Wolfe Research Operator Good …

American Axle & Manufacturing Holdings (AXL) CEO David Dauch on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/4/2019

American Axle & Manufacturing Holdings, Inc. (NYSE: AXL ) Q2 2019 Earnings Conference Call August 2, 2019 10:00 AM Jason Parsons - Director, IR David Dauch - Chairman & CEO Christopher May - VP & CFO Armintas Sinkevicius - Morgan Stanley Joseph Spak - RBC Capital Markets Rod Lache - Wolfe Research Ryan Brinkman - JP Morgan Jason Stuhldreher - Barclays Dan Levy - Credit Suisse James Picariello - KeyBanc Capital Markets John Murphy - Bank of America Operator Good morning. My name is Gary …

Clinical Data

Abeona Therapeutics Inc. (ABEO) CEO João Siffert on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/12/2019

… Timothy Miller - President & Chief Scientific Officer Christine Berni-Silverstein - Chief Financial Officer Conference Call Participants Maury Raycroft - Jefferies Vikram Kaushik - RBC Capital Markets Fang-Ke Huang - SunTrust Robinson Humphrey Liav Abraham - Citigroup Operator Good morning … 101 is the only product in development for RDEB with clinical data showing it could heal large chronic wounds that had been open for years. The Phase 1/2 A trial conducted by Stanford University show …

Alder BioPharmaceuticals, Inc. (ALDR) CEO Bob Azelby on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/9/2019

… Nadia Dac - Chief Commercial Officer Carlos Campoy - Chief Financial Officer Erin Lavelle - Chief Operating Officer Conference Call Participants Brian Abrahams - RBC Capital Markets Yuko Oku - JPMorgan Charles Duncan - Cantor Fitzgerald Jim Birchenough - Wells Fargo Evan … payers with the objective of introducing Alder and sharing epti’s clinical data in partnerships with our field medical team. We feel confident that at the time of launch, payers will make epti widely available for …

Medicare

Encompass Health announces launch of senior notes offering | PR Newswire | 9/9/2019

… repay borrowings under its revolving credit facility. Citigroup; Barclays; BofA Merrill Lynch; Goldman Sachs & Co. LLC; J.P. Morgan; Morgan Stanley; RBC Capital Markets; Regions Securities LLC; SunTrust Robinson Humphrey and Wells Fargo Securities will act … information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health’s services by governmental or private payors; and other factors which may be identified …

Addus HomeCare Announces Public Offering of Common Stock | PR Newswire | 9/3/2019

… will not receive any proceeds from the sale of the shares of common stock by the Selling Stockholders. Jefferies LLC, RBC Capital Markets, LLC and Raymond James & Associates, Inc. are acting as joint book-running … structures at the state or federal levels; changes in Medicaid, Medicare, other government program and managed care organizations policies and payment rates; changes in, or our failure to comply with existing, federal and state laws …

Food and Drug Administration

Sarepta shares are tanking after Duchenne drug setback - MarketWatch | 8/20/2019

Shares of Sarepta Therapeutics Inc. fell 13% Tuesday on the news that the Food and Drug Administration rejected the company’s marketing application for an experimental drug to treat patients with Duchenne muscular dystrophy. Sarepta SRPT … wrist for the prior questionable accelerated approval of Exondys 51.” RBC Capital Markets’ Brian Abrahams thought the same. “We believe this could in some ways be a referendum on the controversial approval of their currently

FDA Approves Celgene’s Bone Marrow Cancer Treatment | Medscape | 8/19/2019

The U.S. Food and Drug Administration on Friday approved Celgene Corp’s Inrebic (fedratinib) to treat certain rare forms of bone marrow cancer called myelofibrosis, making it the second approved drug to treat the disease. Inrebic … which generated $1.4 billion in revenue for Incyte in 2018. RBC Capital Markets analyst Brian Abrahams said that though Inrebic’s label is broad it comes with a black box warning, and given Jakafi’s significant clinical

Biotech

Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/8/2019

… and Chief Medical Officer Conference Call Participants Alethia Young - Cantor Fitzgerald Tazeen Ahmad - Bank of America Merrill Lynch Brian Abrahams - RBC Capital Markets Christopher Marai - Nomura Vincent Chen - Bernstein Brian Skorney - Robert W. Baird Danielle … of sufficient and rapid development and approval pathways in our biotech. Showing the consistency and precision of our RNA platform, we announced positive results for casimersen in the first quarter and we intend to submit …

PTC Therapeutics, Inc. (PTCT) CEO Stuart Peltz on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/7/2019

… June 30, 2019, compared to approximately $227 million at December 31, 2018. We are proud to have built a global biotech company that is in a financial position to continue to execute on our long … Thank you. Our next question comes from Brian Abrahams of RBC Capital Markets. Your line is open. Unidentified Analyst Hi. This is Bert on for Brian. Thank you guys for taking our question. I had …

EDIS

Amedisys to Present at the 2019 RBC Capital Markets Healthcare Conference | Globe Newswire | 5/14/2019

May 14, 2019 12:06 ET Source: Amedisys, Inc. BATON ROUGE, Amedisys, Inc. (NASDAQ: AMED), one of America’s leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 2019 RBC Capital Markets Healthcare Conference in New York City, NY on Tuesday, May 21, 2019. The presentation will begin at 4:05 p.m. Eastern Time. To access a live webcast …

Amedisys to Present at the 2019 RBC Capital Markets Healthcare Conference | Financial Buzz | 5/14/2019

BATON ROUGE, La., Amedisys, Inc. (NASDAQ: AMED), one of America’s leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 2019 RBC Capital Markets Healthcare Conference in New York City, NY on Tuesday, May 21, 2019. The presentation will begin at 4:05 p.m. Eastern Time. To access a live webcast of the Amedisys presentation, please log on …

Medicaid

Addus HomeCare Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares | PR Newswire | 9/9/2019

… future acquisitions or investments, and the repayment of indebtedness outstanding under the Company’s amended and restated credit facility. Jefferies LLC, RBC Capital Markets, LLC and Raymond James & Associates, Inc. acted as joint book-running managers … payment structures at the state or federal levels; changes in Medicaid, Medicare, other government program and managed care organizations policies and payment rates; changes in, or our failure to comply with existing, federal and state …

Addus HomeCare Announces Public Offering of Common Stock | PR Newswire | 9/3/2019

… will not receive any proceeds from the sale of the shares of common stock by the Selling Stockholders. Jefferies LLC, RBC Capital Markets, LLC and Raymond James & Associates, Inc. are acting as joint book-running … payment structures at the state or federal levels; changes in Medicaid, Medicare, other government program and managed care organizations policies and payment rates; changes in, or our failure to comply with existing, federal and state …

Wells Fargo Securities, LLC

PlacementTracker Publishes Q2 2019 PIPE and Private Placement Markets League Tables | PR Newswire | 7/23/2019

RBC Capital Markets, Inc. 6 $1,013,701,904 SVB Leerink LLC 6 $521,212,485 Chardan Capital Markets 6 $209,055,304 B. Riley & Co. 6 $159,504,832 Barclays Capital, Inc. 5 $454,457,336 Wells Fargo Securities, LLC 5 $265,474,996 Sandler O’Neill & Partners, L.P. 5 $129,999,990 Investment Banking rankings exclude all 144-A Offerings, Equity Lines of Credit, At the Market Transactions, Rights Offerings, Bought Deals, and all PIPE transactions conducted by foreign issuers that trade in the …

HealthEquity Announces Closing of Follow-On Offering and Over-Allotment Option | Globe Newswire | 7/12/2019

Wells Fargo Securities, LLC is acting as lead book-running manager for the offering. Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Citigroup Global Markets Inc., RBC Capital Markets, LLC and SunTrust Robinson Humphrey, Inc. are acting as book-running managers for the offering. The offering is being made only by means of the applicable prospectus supplement and accompanying prospectus. You may obtain copies of these documents without charge from …

Celgene

Celgene to sell psoriasis drug Otezla for $13.4 billion to Amgen | Yahoo News | 8/26/2019

… Amgen sign at the company’s office in South San Francisco More (Reuters) - Amgen Inc said on Monday it would buy Celgene Corp’s psoriasis drug Otezla for $13.4 billion in cash, clearing the way for Bristol … valuing a deal for the drug at about $9 billion. RBC Capital Markets analyst Brian Abrahams, who had earlier said that Otezla was a better fit for Gilead Sciences Inc, also pointed to the high …

Amgen to buy Celgene’s psoriasis drug Otezla for $13.4 billion in cash | Yahoo News | 8/26/2019

Bristol-Myers now expects the Celgene deal to close by 2019 end, pushing Celgene’s shares up 3% before the opening bell. Amgen shares, however, fell as some investors worried that the company was shelling out … valuing a deal for the drug at about $9 billion. RBC Capital Markets analyst Brian Abrahams, who had earlier said that Otezla was a better fit for Gilead Sciences Inc, also pointed to the high

Novartis

Amgen, maker of Enbrel, to pick up Celgene’s Otezla for $13.4B. Will FTC hit back? | FiercePharma | 8/26/2019

RBC Capital Markets, Jefferies and Credit Suisse had previously expected a deal could reach $10 billion, tops. Besides Amgen, several immunology players were suspected as potential buyers, including Cosentyx marketer Novartis, Tremfya seller Johnson & Johnson, AbbVie, Eli Lilly and Gilead Sciences, which is hoping to nab an approval for oral JAK inhibitor filgotinib soon. But now, Amgen has emerged as the winner, going well past the $10 billion mark. Still …

Alder BioPharmaceuticals, Inc. (ALDR) CEO Bob Azelby on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/9/2019

… Nadia Dac - Chief Commercial Officer Carlos Campoy - Chief Financial Officer Erin Lavelle - Chief Operating Officer Conference Call Participants Brian Abrahams - RBC Capital Markets Yuko Oku - JPMorgan Charles Duncan - Cantor Fitzgerald Jim Birchenough - Wells Fargo Evan … one quick question on the ongoing lawsuit between Amgen and Novartis regarding the manufacturing of epti. Do you foresee this as a potential risk to commercial supply? Then I have a follow-up question. Bob …

Allergan

Not so fast, Endo and Allergan: Ohio’s AG is looking past your opioid deals | FiercePharma | 8/23/2019

With national opioid litigation heating up, Endo and Allergan saw an off-ramp and took it, agreeing to settle with two Ohio counties for a combined $16 million this week. But the state’s attorney general … the full Cleveland litigation, would indicate a $1.8 billion liability, RBC Capital Markets analyst Ami Fadia said. That’s a far cry from the firm’s the original estimate of around $4 billion. And that good news

Alphabet Inc

Alphabet’s bounce-back quarter has shares, price targets on the rise - MarketWatch | 7/28/2019

A significant bounce in Alphabet Inc.’s Google-related revenue has returned a bounce to the steps of analysts following the company. “Nice rebound from Q1,” Jefferies’ Brent Thill said of Alphabet’s 28% jump in … search, and cloud. “Cloud Killin’ It,” wrote Mark Mahaney or RBC Capital Markets, who had estimated a $7 billion run rate. He raised his price target to $1,425 from $1,300. Alphabet’s management was less forthcoming

Alphabet Sales Top Analyst Estimates, Calming Growth Concern | Yahoo News | 7/27/2019

Bloomberg) – Alphabet Inc. shares jumped the most in four years after the internet giant reported revenue that beat Wall Street expectations, calming concern about slowing growth. Second-quarter sales, excluding payments to partners, came in … run rate was $1 billion higher than the estimate of RBC Capital Markets analyst Mark Mahaney. The results show Google is getting more tenacious in this market. “Here come the cloud wars,” Mahaney wrote in

UnitedHealth

Big 5 payers grow MA market share in August | Healthcare Dive | 8/22/2019

Healthcare, Humana, Aetna, Anthem and Cigna outpaced other competitors in the space, according to RBC Capital Markets. Anthem had the highest percentage growth in August (up 1% or roughly 12,000 members) while Humana and UnitedHealthcare had the strongest gains numerically, with Humana picking up almost 22,500 members and UnitedHealthcare up almost 22,000. Overall MA membership increased 0.4% month-over-month, with the big five insurers gaining 0.5% as a group …

UnitedHealthcare issues coverage for Inspire Medical’s therapy for OSA - Inspire Medical Systems, Inc. (NYSE:INSP) | Seeking Alpha | 7/8/2019

UnitedHealthcare will provide coverage for Inspire Medical Systems’ (NYSE: INSP ), Inspire therapy effective August 1, 2019. Under its policy, UnitedHealthcare considers Inspire’s FDA approved hypoglossal nerve neurostimulation device to be medically necessary for the treatment … the move » Now read: Inspire Medical Systems (INSP) Presents At RBC Capital Markets 2019 Healthcare Conference - Slideshow

CVS Health

CVS launches home hemodialysis device clinical trial | Healthcare Dive | 7/17/2019

First appeared on MedTech Dive Dive Brief: CVS Health announced on Wednesday the start of a clinical trial of up to 70 patients to evaluate the safety and performance of a home hemodialysis device the … the home dialysis market, according to a recent note from RBC Capital Markets. Conversely, hemodialysis uses an artificial kidney machine to pump blood out of a patient to clean the blood before returning it to

Got the flu? Investing in these companies may make you feel better - MarketWatch | 1/18/2018

RBC Capital Markets analyst George Hill said. For the drug supply chain, “catching cold is a good thing,” Hill said, citing CVS Health Corp. CVS, +0.41% Walgreens Boots Alliance WBA, +0.37% and Rite Aid Corp. RAD, -0.50% as particular beneficiaries. Other drug supply chain companies include distributors AmerisourceBergen Corp. ABC, +0.95% Cardinal Health Inc. CAH, +0.90% and McKesson Corp. MCK, +1.56% Read: This year’s flu season could be the most …

Pfizer

Could a ‘creative deal’ between Perrigo, Amneal help reinvent both struggling businesses? | FiercePharma | 8/21/2019

Pfizer and Mylan—be the cure? A “creative deal” between Perrigo and Amneal could bring up to $1.5 billion in cash to the Irish pharma as it works to back away from a disastrous stock price plummet in recent months, according to RBC Capital Markets analyst Randall Stanicky. In a Sunday note to investors, Stanicky outlined four possible options for Perrigo as it looks to an uncertain future for its …

AbbVie’s Rinvoq label portends safety warnings for future JAKs—including Gilead’s | FiercePharma | 8/19/2019

… for RA med Rinvoq, its crucial Humira follow-up It’s a warning consistent with those carried by its fellow JAKs, Pfizer’s Xeljanz and Eli Lilly’s Olumiant, despite Rinvoq “having a better safety profile in its … see peak sales between $3 billion and $5 billion. And RBC Capital Markets’ Brian Abrahams isn’t too worried about Rinvoq or filgotinib, either. The language on Rinvoq’s label “is much less strong than for Xeljanz …

AbbVie

Amgen, maker of Enbrel, to pick up Celgene’s Otezla for $13.4B. Will FTC hit back? | FiercePharma | 8/26/2019

RBC Capital Markets, Jefferies and Credit Suisse had previously expected a deal could reach $10 billion, tops. Besides Amgen, several immunology players were suspected as potential buyers, including Cosentyx marketer Novartis, Tremfya seller Johnson & Johnson, AbbVie, Eli Lilly and Gilead Sciences, which is hoping to nab an approval for oral JAK inhibitor filgotinib soon. But now, Amgen has emerged as the winner, going well past the $10 billion mark. Still …

Endo strikes $10M opioid settlement with just two Ohio counties, and Allergan may not be far behind | FiercePharma | 8/20/2019

RBC Capital Markets expect Endo to be on the hook for $2.1 billion. Allergan, which is merging with AbbVie in a $63 billion deal, faces about 2,000 opioid lawsuits, according to an SEC filing (PDF). The latest settlement amounts pale in comparison to opioid settlements reached by Teva and Purdue in Oklahoma’s lawsuit against opioid drugmakers. Purdue struck a $270 million deal to resolve the state’s claims, while Teva agreed …

Merck

Stocks making the biggest moves midday: DaVita, AMD, 3M, Acacia Communications and more | Yahoo News | 7/10/2019

RBC Capital Markets downgraded the stock to sector perform from outperform. “After an unsettling string of guidance cuts, 3M’s reputation as a defensive, high-quality industrial is eroding,” the analyst wrote. Merck & Co.— Shares of Merck rose more than 1% after the company said the Food and Drug Administration accepted its license applications to update dosing for its drug KEYTRUDA, which helps the body’s immune system detect and fight tumor …

Goldman Sachs

Encompass Health announces launch of senior notes offering | PR Newswire | 9/9/2019

Goldman Sachs & Co. LLC; J.P. Morgan; Morgan Stanley; RBC Capital Markets; Regions Securities LLC; SunTrust Robinson Humphrey and Wells Fargo Securities will act as joint book-running managers of the offering. This debt offering is being made pursuant to an effective shelf registration statement on Form S-3 (Registration No. 333-220519) filed with the Securities and Exchange Commission. This offering is being made solely by means of a prospectus supplement …

Canada Goose Holdings Inc. (GOOS) Q1 2020 Earnings Call Transcript - Nasdaq.com | 8/15/2019

… we don’t see changing. Omar Saad – Evercore ISI – Analyst Thank you. Operator Your next question comes from Kate Fitzsimons from RBC Capital Markets. Your line is open. Kate Fitzsimons – RBC Capital Markets – Analyst Yes, hi … product. Operator Your next question comes from Alexandra Walvis from Goldman Sachs. Your line is open. Rosalie Frazier – Goldman Sachs – Analyst Hi. This is Rosalie on behalf of Alex. On tourist spend, you mentioned strong …

Merrill Lynch

Encompass Health announces launch of senior notes offering | PR Newswire | 9/9/2019

Merrill Lynch; Goldman Sachs & Co. LLC; J.P. Morgan; Morgan Stanley; RBC Capital Markets; Regions Securities LLC; SunTrust Robinson Humphrey and Wells Fargo Securities will act as joint book-running managers of the offering. This debt offering is being made pursuant to an effective shelf registration statement on Form S-3 (Registration No. 333-220519) filed with the Securities and Exchange Commission. This offering is being made solely by means of a …

Kilroy Realty, L.P. Prices $500.0 Million of 3.050% Senior Notes Due 2030 | Business Wire | 9/3/2019

Merrill Lynch, PNC Capital Markets LLC, RBC Capital Markets and Scotiabank acted as senior co-managers and BBVA, BNP PARIBAS, Citigroup, Comerica Securities, J.P. Morgan and KeyBanc Capital Markets acted as co-managers of the offering. Net proceeds from the offering will be approximately $495.2 million, after deducting the underwriting discount and the Company’s estimated expenses. The Company intends to use the net proceeds from the offering for general corporate …

Morgan Stanley

Encompass Health announces launch of senior notes offering | PR Newswire | 9/9/2019

Morgan Stanley; RBC Capital Markets; Regions Securities LLC; SunTrust Robinson Humphrey and Wells Fargo Securities will act as joint book-running managers of the offering. This debt offering is being made pursuant to an effective shelf registration statement on Form S-3 (Registration No. 333-220519) filed with the Securities and Exchange Commission. This offering is being made solely by means of a prospectus supplement and accompanying prospectus which has been …

Broader Market Drags Affecting Salesforce Could Drive Buying Opportunity - RealMoney | TheStreet | 8/23/2019

… 200 billion TAM and strong secular tailwinds to make CRM one of the best positioned software stocks in today’s environment,” Morgan Stanley analyst Keith Weiss said. “CRM is one of the best secular stories in … a uniquely strong CEO duo driving the vision and execution,” RBC Capital Markets analyst Alex Zukin said. “We continue to believe that CRM’s co-CEO’s, Marc Benioff and Keith Block, represent a team that combines …

Citigroup

Encompass Health announces launch of senior notes offering | PR Newswire | 9/9/2019

Citigroup; Barclays; BofA Merrill Lynch; Goldman Sachs & Co. LLC; J.P. Morgan; Morgan Stanley; RBC Capital Markets; Regions Securities LLC; SunTrust Robinson Humphrey and Wells Fargo Securities will act as joint book-running managers of the offering. This debt offering is being made pursuant to an effective shelf registration statement on Form S-3 (Registration No. 333-220519) filed with the Securities and Exchange Commission. This offering is being made solely by …

Abeona Therapeutics Inc. (ABEO) CEO João Siffert on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/12/2019

Abeona Therapeutics Inc. (NASDAQ: ABEO ) Q2 2019 Earnings Conference Call August 12, 2019 10:00 AM ET Company Participants Sofia Warner - Senior Director, Investor Relations João Siffert - Chief Executive Officer, Head of Research & Development and Chief Medical Officer Timothy Miller - President & Chief Scientific Officer Christine Berni-Silverstein - Chief Financial Officer Conference Call Participants Maury Raycroft - Jefferies Vikram Kaushik - RBC Capital Markets Fang-Ke Huang - SunTrust Robinson Humphrey Liav Abraham - Citigroup Operator …

SunTrust Robinson Humphrey

BMC Stock Holdings, Inc. (BMCH) CEO David Flitman on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/11/2019

RBC Capital Markets, LLC Keith Hughes - SunTrust Robinson Humphrey, Inc. Min Cho - B. Riley FBR, Inc. Operator Good morning and thank you for standing by. You are joining BMC’s Second Quarter 2019 Earnings Conference Call. This call is being recorded today, Tuesday, August 6, 2019. Carey Phelps, Vice President of Investor Relations for BMC, will now provide the company’s opening remarks. Carey Phelps Thank you. Good morning and welcome. After …

Lightyear Capital and PSP Investments Close on Sale of Advisor Group to Reverence Capital Partners | Business & Finance | heraldchronicle.com | Business Wire | 8/2/2019

RBC Capital Markets, LLC and SunTrust Robinson Humphrey, Inc. also provided financial advice to the Company. Simpson Thacher & Bartlett LLP acted as legal counsel to the Company. About Lightyear Capital LLC Founded in 2000, Lightyear is a financial services-focused private equity firm based in New York. Through its affiliated private equity funds, Lightyear makes primarily control investments in North America-based, middle-market companies across the financial services spectrum …

William Blair

Addus HomeCare Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares | PR Newswire | 9/9/2019

RBC Capital Markets, LLC and Raymond James & Associates, Inc. acted as joint book-running managers for the offering. Robert W. Baird & Co. Incorporated, Oppenheimer & Co. Inc., Stephens Inc., William Blair & Company, L.L.C., BMO Capital Markets Corp., and Sidoti & Company, LLC acted as co-managers. An automatic shelf registration statement (including a prospectus) relating to the offering of Common Stock was filed with the U.S. Securities and Exchange Commission (the “SEC …

Addus HomeCare Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares | BioSpace | 9/9/2019

RBC Capital Markets, LLC and Raymond James & Associates, Inc. acted as joint book-running managers for the offering. Robert W. Baird & Co. Incorporated, Oppenheimer & Co. Inc., Stephens Inc., William Blair & Company, L.L.C., BMO Capital Markets Corp., and Sidoti & Company, LLC acted as co-managers. An automatic shelf registration statement (including a prospectus) relating to the offering of Common Stock was filed with the U.S. Securities and Exchange Commission (the “SEC …

Jefferies Financial Group

Abeona Therapeutics Inc. (ABEO) CEO João Siffert on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/15/2019

Abeona Therapeutics Inc. (NASDAQ: ABEO ) Q1 2019 Earnings Conference Call May 14, 2019 10:00 AM ET Company Participants Sofia Warner - Senior Director, Investor Relations João Siffert - Chief Executive Officer, Head of Research & Development and Chief Medical Officer Timothy Miller - President and Chief Scientific Officer Christine Berni-Silverstein - Chief Financial Officer Conference Call Participants David Steinberg - Jefferies & Company, Inc. Liav Abraham - Citigroup Edward Marks - H.C. Wainwright & Co., LLC, Fang-Ke Huang …

Marriott International, Inc. (MAR) CEO Arne Sorenson on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/11/2019

Marriott International, Inc. (NASDAQ: MAR ) Q1 2019 Earnings Conference Call May 10, 2019 1:00 PM ET Company Participants Arne Sorenson - President, CEO and Director Kathleen Oberg - EVP and CFO Laura Paugh - SVP, IR Betsy Dahm - Senior Director, IR Relations Conference Call Participants David Katz - Jefferies Shaun Kelley - Bank of America Merrill Lynch Jared Shojaian - Wolfe Research Joe Greff - JP Morgan David Beckel - Bernstein Smedes Rose - Citi Anthony Powell - Barclays Capital …

JP Morgan

Acceleron Pharma Inc. (XLRN) CEO Habib Dable on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/6/2019

… VP, IR and Corporate Communications Conference Call Participants Andrew Berens - UBS Yaron Werber - Cowen Danielle Brill - Piper Jaffray Eric Joseph - JP Morgan Martin Auster - Credit Suisse Geoffrey Porges - SVB Leerink Yigal Nochomovitz - Citigroup Leland Gershell … Thank you. Our next question comes from Kennon MacKay of RBC Capital Markets. Your line is open. Unidentified Analyst Hey guys, this is Vikram on for Kennon. I had a follow up on the 25 …

American Axle & Manufacturing Holdings (AXL) CEO David Dauch on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/4/2019

American Axle & Manufacturing Holdings, Inc. (NYSE: AXL ) Q2 2019 Earnings Conference Call August 2, 2019 10:00 AM Jason Parsons - Director, IR David Dauch - Chairman & CEO Christopher May - VP & CFO Armintas Sinkevicius - Morgan Stanley Joseph Spak - RBC Capital Markets Rod Lache - Wolfe Research Ryan Brinkman - JP Morgan Jason Stuhldreher - Barclays Dan Levy - Credit Suisse James Picariello - KeyBanc Capital Markets John Murphy - Bank of America Operator Good morning. My name is Gary …

J.P. Morgan Securities

Medical Properties Trust Announces Pricing of Public Offering of Common Stock – Company Announcement - FT.com | Financial Times | 7/16/2019

… representatives of the underwriters for the offering. Credit Agricole CIB, Goldman Sachs & Co. LLC , KeyBanc Capital Markets , MUFG, Raymond James , RBC Capital Markets , Stifel, SunTrust Robinson Humphrey and Wells Fargo Securities also acted as joint … Prospectus Department or by email at [email protected] , from J.P. Morgan Securities LLC , c/o Broadridge Financial Solutions , 1155 Long Island Avenue , Edgewood, NY 11717, or by phone at (866) 803-9204, or by visiting …

HealthEquity Announces Closing of Follow-On Offering and Over-Allotment Option | Globe Newswire | 7/12/2019

J.P. Morgan Securities LLC, Citigroup Global Markets Inc., RBC Capital Markets, LLC and SunTrust Robinson Humphrey, Inc. are acting as book-running managers for the offering. The offering is being made only by means of the applicable prospectus supplement and accompanying prospectus. You may obtain copies of these documents without charge from the Securities and Exchange Commission (the “SEC”). Alternatively, you may request these documents from Wells Fargo Securities, LLC …

JMP Securities

AquaVenture Holdings Limited (WAAS) CEO Tony Ibarguen on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/10/2019

AquaVenture Holdings Limited (NYSE: WAAS ) Q2 2019 Earnings Conference Call August 7, 2019 8:00 AM ET Company Participants Courtney Denihan - Investor Relations Tony Ibarguen - President and CEO Doug Brown - Chairman and Founder Lee Muller - Senior Vice President and CFO Conference Call Participants Rob Brown - Lake Street Capital Markets Vladimir Bystricky - Citi Deane Dray - RBC Capital Markets Jeff Van Sinderen - B. Riley & Co Joseph Osha - JMP Securities Pavel Molchanov - Raymond James …

Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/8/2019

RBC Capital Markets Christopher Marai - Nomura Vincent Chen - Bernstein Brian Skorney - Robert W. Baird Danielle Brill - Piper Jaffray Timothy Lugo - William Blair Ross Weinreb - Goldman Sachs Joseph Schwartz - SVB Leerink Timothy Chiang - BTIG Liisa Bayko - JMP Securities Operator Good day, ladies and gentlemen, and welcome to the Sarepta Therapeutics Second Quarter 2019 Earnings Call. At this time, all participants are in a listen-only mode. Later, we will conduct a …

HCA

Big 5 payers grow MA market share in August | Healthcare Dive | 8/22/2019

Healthcare, Humana, Aetna, Anthem and Cigna outpaced other competitors in the space, according to RBC Capital Markets. Anthem had the highest percentage growth in August (up 1% or roughly 12,000 members) while Humana and UnitedHealthcare had the strongest gains numerically, with Humana picking up almost 22,500 members and UnitedHealthcare up almost 22,000. Overall MA membership increased 0.4% month-over-month, with the big five insurers gaining 0.5% as a group …

Permira in $2.4 bln buy of Cambrex | PE Hub | 8/7/2019

… We are very excited to back Cambrex in its next phase of growth,” said Henry Minello, Principal in the Global Healthcare Group of Permira. “Over many years, Cambrex has built a leading position with best … Kirkland & Ellis, LLP is serving as legal advisor to Cambrex. RBC Capital Markets is acting as exclusive financial advisor and provided committed debt financing to the Permira funds and Skadden, Arps, Slate, Meagher & Flom, LLP …

Genesis Healthcare

Genesis HealthCare to Present at 2019 RBC Capital Markets Global Healthcare Conference | Financial Buzz | 5/14/2019

KENNETT SQUARE, Pa., Genesis Healthcare, Inc. (Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced that George V. Hager, Jr., Chief Executive Officer, and Tom DiVittorio, Chief Financial Officer, will host a fireside chat at the 2019 RBC Capital Markets Global Healthcare Conference on Wednesday, May 22, 2019 at 9:30 AM Eastern Time. The conference is being held at the InterContinental Barclay …

Acadia Healthcare

How Analysts Feel About Acadia Healthcare Company, Inc. (NASDAQ:ACHC)? | 4/16/2019

How Analysts Feel About Acadia Healthcare Company, Inc. (NASDAQ:ACHC)? Posted by Louis Casey 32 pm Investors sentiment decreased to 0.94 in 2018 Q4. Its down 0.69, from 1.63 in 2018Q3. It worsened, as 29 … The firm earned “Buy” rating on Monday, March 4 by RBC Capital Markets. Stephens maintained Acadia Healthcare Company, Inc. (NASDAQ:ACHC) rating on Monday, March 11. Stephens has “Buy” rating and $37 target. The firm

Acadia Healthcare Company, Inc. (ACHC) Analysts See $0.35 EPS | Money Making Articles | 4/15/2019

Acadia Healthcare Company, Inc. (ACHC) Analysts See $0.35 EPS Posted by Ash 46 am Investors sentiment decreased to 0.94 in 2018 Q4. Its down 0.69, from 1.63 in 2018Q3. It is negative, as 29 investors … per Monday, March 4, the company rating was maintained by RBC Capital Markets. The firm has “Hold” rating by BMO Capital Markets given on Tuesday, March 5. The firm has “Hold” rating given on Friday

Community Health Systems

Community Health Systems’ (CYH) CEO Wayne Smith on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/6/2019

Community Health Systems, Inc. (NYSE: CYH ) Q2 2019 Earnings Conference Call August 6, 2019 11:00 AM ET Company Participants Ross Comeaux – Vice President-Investor Relations Wayne Smith – Chairman and Chief Executive Officer Tim Hingtgen – President and Chief Operating Officer Tom Aaron – Executive Vice President and Chief Financial Officer Conference Call Participants Frank Morgan – RBC Capital Markets A.J. Rice – Credit Suisse Josh Raskin – Nephron Research Brian Tanquilut – Jefferies Ralph Giacobbe – Citigroup …

Community Health Systems, Inc. (CYH) CEO Wayne Smith on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/1/2019

Community Health Systems, Inc. (NYSE: CYH ) Q1 2019 Earnings Conference Call May 1, 2019 11:00 AM ET Company Participants Ross Comeaux - Vice President of Investor Relations Wayne Smith - Chairman & Chief Executive Officer Tim Hingtgen - President & Chief Operating Officer Tom Aaron - Executive Vice President & Chief Financial Officer Lynn Simon - President of Clinical Operations & Chief Medical Officer Conference Call Participants Frank Morgan - RBC Capital Markets A.J. Rice - Credit Suisse Josh Raskin - Nephron …

Quorum Health Corporation

Quorum Health Corporation (QHC) CEO Bob Fish on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/11/2019

Quorum Health Corporation (NYSE: QHC ) Q1 2019 Results Conference Call May 10, 2019 11:00 AM Bob Fish - President and CEO Alfred Lumsdaine - CFO Marty Smith - COO Conference Call Participants Zack Sopcak - Morgan Stanley Frank Morgan - RBC Capital Markets Jason Adler - UBS Rishi Parekh - Barclays Operator Good morning, and welcome to Quorum Health Corporation’s First Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen only mode …

Quorum Health Corporation to Participate in May Investor Conferences | Business Wire | 5/6/2019

BRENTWOOD, Tenn.- Quorum Health Corporation (NYSE: QHC) announced today that members of the Company’s management team will present at the following investor conferences during the month of May: Wednesday, May 15, 2019 at 10:40 a.m. (EDT) at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada. Wednesday, May 22, 2019 at 8:00 a.m. (EDT) at the 2019 RBC Capital Markets Global Healthcare Conference in New York …

Dignity Health

Select Medical Holdings’ (SEM) Management on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/3/2019

… Company Participants Robert Ortenzio – Executive Chairman and Co-founder Martin Jackson – Executive Vice President and Chief Financial Officer Frank Morgan – RBC Capital Markets Peter Costa – Wells Fargo A.J. Rice – Credit Suisse Kevin Fischbeck – Bank of … rehabilitation hospitals under construction in Las Vegas in partnership with Dignity Health scheduled to open the second quarter and in Newport News Virginia in partnership with Riverside Health scheduled to open in the third quarter …

Select Medical Holdings Corp (SEM) Q1 2019 Earnings Call Transcript - Nasdaq.com | 5/3/2019

… UC San Diego Health in the first quarter. We have rehabilitation hospitals under construction in Las Vegas, in partnership with Dignity Health, is scheduled to open the second quarter and in Newport News Virginia in … first question comes from the line of Frank Morgan with RBC Capital Markets your line is open. Frank Morgan – RBC Capital Markets – Analyst Good morning. I guess, I’ll start with a high level and going …

HCA Healthcare

HCA Healthcare, Inc. (HCA) CEO Samuel Hazen on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/1/2019

HCA Healthcare, Inc. (NYSE: HCA ) Q1 2019 Earnings 10:00 AM Mark Kimbrough - Vice President of Investor Relations Samuel Hazen - Chief Executive Officer William Rutherford - Executive Vice President and Chief Financial Officer Gary Taylor - JP Morgan Chase & Co. Pito Chickering - Deutsche Bank A.J. Rice - Credit Suisse Frank Morgan - RBC Capital Markets LLC Peter Costa - Wells Fargo Securities Michael Newshel - Evercore ISI Ann Hynes - Mizuho Securities Co., Ltd. Matthew Gillmor - Robert W …

HCA Healthcare, Inc. to Present at May Healthcare Conferences | 4/24/2019

24/04/2019 HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences in May 2019. May 21, 2019 at 1:30 p.m. (EDT) at the UBS Global Healthcare Conference held at the Grand Hyatt in New York, NY. May 22, 2019 at 9:00 a.m. (EDT) at the 2019 RBC Capital Markets Global Healthcare Conference held at the InterContinental New York Barclay in New York, NY. A link to …

HealthSouth

This Morning’s Technical Outlook on Specialized Health Services Stocks – Acadia Healthcare, | PR Newswire | 11/28/2017

Home This Morning’s Technical Outlook on Specialized Health Services Stocks – Acadia Healthcare, DaVita, HealthSouth, and MEDNAX This Morning’s Technical Outlook on Specialized Health Services Stocks – Acadia Healthcare, DaVita, HealthSouth, and MEDNAX Nov 28, 2017 PR Newswire A daily sales rate of 54,430 marks a 0.6% decline from November 2016…. More Advertisement FCA and regulators reach an agreement to allow certification of the automaker’s 3.0L EcoDiesel engine…. More Advertisement When I …

This Morning’s Technical Outlook on Specialized Health Services Stocks – Acadia Healthcare, DaVita, HealthSouth, and MEDNAX | PR Newswire | 11/28/2017

… away at http://www.wallstequities.com/registration . Pre-market today, WallStEquities.com scans Acadia Healthcare Co. Inc. (NASDAQ: ACHC), DaVita Inc. (NYSE: DVA), HealthSouth Corp. (NYSE: HLS), and MEDNAX Inc. (NYSE: MD ). Specialized Health Services companies produce and … for dialysis patients. On November 08 th , 2017, research firm RBC Capital Markets reiterated its ‘Sector Perform’ rating on the Company’s stock with a decrease of the target price from $64 a share to $60 …

VITAS Healthcare

Chemed Corporation (CHE) CEO Kevin McNamara on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 7/26/2019

Chemed Corporation (NYSE: CHE ) Q2 2019 Earnings Conference Call July 26, 2019 10:00 AM ET Company Participants Sherri Warner - IR Kevin McNamara - President and CEO David Williams - EVP and CFO Nicholas Westfall - CEO, VITAS Healthcare Corporation Subsidiary Conference Call Participants Joanna Gajuk - Bank of America Merrill Lynch Frank Morgan - RBC Capital Markets Operator Hello and welcome to the Chemed Corporation Second Quarter 2019 Earnings Call. [Operator Instructions] As a reminder …

Chemed Corporation to Present at the 2019 RBC Capital Markets Global Healthcare Conference | Benzinga | 5/14/2019

Chemed Corporation (NYSE: CHE ) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 21, 2019, at approximately 11:00 a.m. (ET) at The InterContinental New York … Cincinnati, Ohio, Chemed Corporation ( www.chemed.com ) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation’s largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider

Tenet Healthcare Corporation

Tenet Healthcare Corporation (THC) CEO Ron Rittenmeyer on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/1/2019

Tenet Healthcare Corporation (NYSE: THC ) Q1 2019 Earnings 9:00 AM Brendan Strong - Vice President, Investor Relations Ron Rittenmeyer - Executive Chairman & Chief Executive Officer Dan Cancelmi - Chief Financial Officer Brett Brodnax - President and Chief Executive Officer … Ana Gupte - SVB Leerink Matthew Gillmor - Robert Baird Frank Morgan - RBC Capital Markets Patrick Philippe - Barclays Matt Larew - William Blair Steve Tanal - Goldman Sachs Operator Good day and welcome the Tenet Healthcare Q1 2019 Earnings

Tenet Healthcare Corporation (THC) EPS Estimated At $0.34 | 4/15/2019

Tenet Healthcare Corporation (THC) EPS Estimated At $0.34 Posted by Adrian Erickson 06 pm Investors sentiment decreased to 1.29 in 2018 Q4. Its down 0.26, from 1.55 in 2018Q3. It dropped, as 28 investors sold … Hold” rating and $29 target in Tuesday, February 26 report. RBC Capital Markets maintained Tenet Healthcare Corporation (NYSE:THC) on Tuesday, February 26 with “Hold” rating. Citigroup maintained it with “Buy” rating and $37 target

Aetna

CVS launches home hemodialysis device clinical trial | Healthcare Dive | 7/17/2019

… receive dialysis at home or receive a viable organ transplant by 2025. Dive Insight: CVS, which now includes insurance giant Aetna, argues it can help the government reduce costs associated with the treatment of end … the home dialysis market, according to a recent note from RBC Capital Markets. Conversely, hemodialysis uses an artificial kidney machine to pump blood out of a patient to clean the blood before returning it to …

Pacira Biosciences, Inc. (PCRX) CEO David Stack on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/3/2019

… Chairman & CEO Richard Scranton - Chief Medical Officer Charles Reinhart - CFO Conference Call Participants David Amsellem - Piper Jaffray Companies Randall Stanicky - RBC Capital Markets David Steinberg - Jefferies Vasiliana Moussatos - Wedbush Securities Gary Nachman - BMO Capital Markets … a payer-by-payer basis. Our ASC pilot program with Aetna has delivered results, and we are now meaningfully expanding this program into a national initiative. As you may recall, Aetna has a stated corporate …

Anthem

Pre-market Technical Scan on Healthcare Equities – Anthem, Cigna, Amedisys, and BioScrip | PR Newswire | 11/30/2017

Pre-market Technical Scan on Healthcare Equities – Anthem, Cigna, Amedisys, and BioScrip News provided by Share this article NEW YORK , Nov. 30, In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com … RSI of 64.88. On November 03 rd , 2017, research firm RBC Capital Markets reiterated its ‘Outperform’ rating on the Company’s stock with an increase of the target price from $185 a share to $220 a

Humana

Stocks making the biggest moves midday: Alphabet, Facebook, DuPont & more | Yahoo News | 6/4/2019

… line” execution from management. The stock rose 3.2%. Waste Management —Shares of Waste Management climbed more than 1% after an RBC Capital Markets analyst upgraded the stock to outperform from market perform. “We see Waste … billion. Infineon’s share price fell 9% Monday on the news. Humana — Shares of Humana gained 1.2% after an SEC filing revealed that the company is not interested in merging with health insurer Centene. This deal …

UnitedHealthcare

Big 5 payers grow MA market share in August | Healthcare Dive | 8/22/2019

Healthcare, Humana, Aetna, Anthem and Cigna outpaced other competitors in the space, according to RBC Capital Markets. Anthem had the highest percentage growth in August (up 1% or roughly 12,000 members) while Humana and UnitedHealthcare had the strongest gains numerically, with Humana picking up almost 22,500 members and UnitedHealthcare up almost 22,000. Overall MA membership increased 0.4% month-over-month, with the big five insurers gaining 0.5% as a group …

UnitedHealthcare issues coverage for Inspire Medical’s therapy for OSA - Inspire Medical Systems, Inc. (NYSE:INSP) | Seeking Alpha | 7/8/2019

UnitedHealthcare will provide coverage for Inspire Medical Systems’ (NYSE: INSP ), Inspire therapy effective August 1, 2019. Under its policy, UnitedHealthcare considers Inspire’s FDA approved hypoglossal nerve neurostimulation device to be medically necessary for the treatment … the move » Now read: Inspire Medical Systems (INSP) Presents At RBC Capital Markets 2019 Healthcare Conference - Slideshow

Cigna

Teva Pharmaceutical Industries Ltd (TEVA) CEO Kare Schultz on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/2/2019

… Navin Jacob - UBS Gary Nachman - BMO Capital Markets Liav Abraham - Citi Esther Rajavelu - Oppenheimer David Maris - Wells Fargo Randall Stanicky - RBC Capital Markets David Amsellem - Piper Jeffrey Gregg Gilbert - SunTrust Umer Raffat - Evercore Elliot Wilbur … access to Express Scripts National Preferred Formulary on April 1st. Cigna is also reimbursing AJOVY. So our coverage continues to expand. And as I mentioned in previous calls, it’s going to be a continued discussion …

Anthem, Inc. (ANTM) CEO Gail Boudreaux on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 4/24/2019

… Sopcak - Morgan Stanley Kevin Fischbeck - Bank of America Dave Windley - Jefferies Steve Tanal - Goldman Sachs Scott Fidel - Stephens Frank Morgan - RBC Capital Markets Lance Wilkes - Sanford Bernstein Operator Ladies and gentlemen, thank you for standing … Blue Cross, Blue Shield Association. If you look at the Cigna litigation, it seems like you guys thought that the MDL litigation might actually settle with them a couple of years and that seems to …

Wellcare

Stocks making the biggest moves midday: Alphabet, Facebook, DuPont & more | Yahoo News | 6/4/2019

… line” execution from management. The stock rose 3.2%. Waste Management —Shares of Waste Management climbed more than 1% after an RBC Capital Markets analyst upgraded the stock to outperform from market perform. “We see Waste … This deal would have diverged from Centene’s plans to acquire WellCare Health Plans. Centene shares dropped more than 9%. Nektar Therapeutics — The biotechnology stock rose jumped nearly 10% after the company released positive trial results …

Molina Healthcare

Got the flu? Investing in these companies may make you feel better - MarketWatch | 1/18/2018

… analysts. That demand is also expected to continue “as experts anticipate flu season getting worse over the next couple months,” RBC Capital Markets analyst George Hill said. For the drug supply chain, “catching cold is … activity among members based on their regional footprints, while for Molina Healthcare Inc. MOH, +0.19% it may be slightly lower, Borsch said. “That said, flu impact does not change our bias for Payers over Providers …

Stock Review for Health Care Plans Investors – CVS Health, Molina Healthcare, UnitedHealth, and Humana | PR Newswire | 12/7/2017

… red. This Thursday, WallStEquities.com has initiated reports coverage on the following Health Care Plans equities: CVS Health Corp. (NYSE: CVS), Molina Healthcare Inc. (NYSE: MOH), UnitedHealth Group Inc. (NYSE: UNH), and Humana Inc. (NYSE: HUM … RSI of 54.48. On November 09 th , 2017, research firm RBC Capital Markets reiterated its ‘Sector Perform’ rating on the Company’s stock with a decrease of the target price from $245 a share to $242 …

Independent Health

HealthEquity Announces Closing of Follow-On Offering and Over-Allotment Option | Globe Newswire | 7/12/2019

… 2019 16:01 ET Source: HealthEquity, Inc. DRAPER, Utah, July 12, 2019 (GLOBE NEWSWIRE) – HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest independent health savings account non-bank custodian, today announced the closing of the underwritten public … Co. LLC, J.P. Morgan Securities LLC, Citigroup Global Markets Inc., RBC Capital Markets, LLC and SunTrust Robinson Humphrey, Inc. are acting as book-running managers for the offering. The offering is being made only by …

HealthEquity Announces Pricing of Public Offering of Common Stock Nasdaq:HQY | Globe Newswire | 7/9/2019

July 09, 2019 19:29 ET Source: HealthEquity, Inc. DRAPER, Utah, July 09, HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest independent health savings account non-bank custodian, today announced the pricing of the previously announced underwritten … Co. LLC, J.P. Morgan Securities LLC, Citigroup Global Markets Inc., RBC Capital Markets, LLC and SunTrust Robinson Humphrey, Inc. are acting as book-running managers for the offering. The offering is being made only by

The Health Plan

CareTrust REIT (CTRE) CEO Greg Stapley on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/9/2019

… Director, Asset Management Conference Call Participants Jordan Sadler - KeyBanc Capital Markets Chad Vanacore - Stifel Jonathan Hughes - Raymond James Michael Carroll - RBC Capital Markets Daniel Bernstein - Capital One John Kim - BMO Capital Markets Operator Good day … are really giving in with the hospital networks. And with the health plans and a securing relationships and their leadership in those markets have started to mature. And so you’re seeing the fruits of those …

Humana Inc. (HUM) CEO Bruce Broussard on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/1/2019

… Wolfe Research Kevin Fischbeck - Bank of America Josh Raskin - Nephron Research Dave Windley - Jefferies A.J. Rice - Credit Suisse Frank Morgan - RBC Capital Markets Scott Fidel - Stephens Sarah James - Piper Jaffray Steven Valiquette - Barclays Michael Newshel … of better-than-expected utilization, which is a positive for the health plan and Humana overall. Accordingly, we are lowering our full-year largely inter-segment revenue guidance to approximately $25.1 billion to $25.6 billion …

Donald Trump

CMS updates Medicare Plan Finder following stakeholder pressure | Healthcare Dive | 8/27/2019

… find Part D coverage. It’s unlikely to have a material impact on other coverage comparison sites like eHealth, according to RBC Capital Markets. “While the government’s mobile user interface, which allows customers to get plan … next decade. The New York Times has reported that President Donald Trump is considering cutting funds for the program in his second term to pare down the deficit. The Hospital Insurance Trust Fund, which finances …

Stock market news: August 20, 2019 | Yahoo News | 8/20/2019

… attention to this week’s slate of earnings. Meanwhile, market participants also digested conflicting statements from White House officials and President Donald Trump himself over whether the administration was considering a payroll tax cut , which would … as investors considered the report. In a note Tuesday morning, RBC Capital Markets analyst Scot Ciccarelli called Home Depot’s results “a solid print in today’s environment.” Traders and financial professionals work on the floor of …

Brian Abrahams

Celgene to sell psoriasis drug Otezla for $13.4 billion to Amgen | Yahoo News | 8/26/2019

RBC Capital Markets analyst Brian Abrahams, who had earlier said that Otezla was a better fit for Gilead Sciences Inc, also pointed to the high price that Amgen was offering. Otezla brought in sales of $1.61 billion last year. Amgen said it expected the drug’s sales to grow at least in the low-double digits over the next five years. (For an interactive on Otezla sales click here: https://fingfx.thomsonreuters.com …

Amgen to buy Celgene’s psoriasis drug Otezla for $13.4 billion in cash | Yahoo News | 8/26/2019

RBC Capital Markets analyst Brian Abrahams, who had earlier said that Otezla was a better fit for Gilead Sciences Inc, also pointed to the high price that Amgen was offering. Otezla brought in sales of $1.61 billion last year. Amgen said it expected the drug’s sales to grow at least in the low-double digits over the next five years. (For an interactive on Otezla sales click here: https://tmsnrt.rs …

Randall Stanicky

Could a ‘creative deal’ between Perrigo, Amneal help reinvent both struggling businesses? | FiercePharma | 8/21/2019

RBC Capital Markets analyst Randall Stanicky. In a Sunday note to investors, Stanicky outlined four possible options for Perrigo as it looks to an uncertain future for its prescription business. Earlier this month, the drugmaker opted to postpone its spinoff plans as pricing pressure threatened to upend a branded OTC business that would be left behind by a split. Survey Survey: The Critical Role of Innovation in Launching Successful OTC …

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/10/2019

Start Time: 10:00 January 1, 0000 10:43 AM ET Evofem Biosciences, Inc. (NASDAQ: EVFM ) Q2 2019 Earnings Conference Call August 06, 2019, 11:00 AM ET Company Participants Saundra Pelletier - CEO Jay File - CFO Russ Barrans - CCO Kelly Culwell - CMO Amy Raskopf - IR Conference Call Participants Randall Stanicky - RBC Capital Markets Leland Gershell - Oppenheimer & Co. Yasmeen Rahimi - ROTH Capital Partners Edward White - H.C. Wainwright Carl Byrnes - Northland Capital Operator Good day …

Sandler O'Neill

SS&C Technologies Holdings, Inc. (SSNC) CEO Bill Stone on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 7/30/2019

RBC Capital Markets Alex Kramm - UBS Rayna Kumar - Evercore ISI Andrew Schmidt - Citi Surinder Thind - Jefferies Ken Hill - Rosenblatt Securities Peter Heckmann - Davidson Chris Schuttler - William Blair Chris Donat - Sandler O’Neill Ashish Sabadra - Deutsche Bank Mayank Tandon - Needham & Company Jackson Ader - JPMorgan Patrick O’Shaughnessy - Raymond James Operator Good afternoon. My name is Sheryl and I will be your conference operator today. At this time, I would like to welcome everyone …

Wintrust Financial Corporation (WTFC) CEO Edward Joseph Wehmer on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 7/17/2019

… 2:00 PM ET Company Participants Edward Joseph Wehmer - President & CEO David Stoehr - CFO David Dykstra - Senior EVP & COO Jon Arfstrom - RBC Capital Markets David Long - Raymond James Nathan Race - Piper Jaffray Michael Young - SunTrust Brad … question will come from the line of Brad Milsaps with Sandler O’Neill. Your line is now open. Brad Milsaps Hey, good afternoon guys. Edward Joseph Wehmer Hi, Brad. Brad Milsaps Hey, Ed, you’ve addressed almost …

John Roberts

Venator Materials PLC (VNTR) CEO Simon Turner on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/10/2019

John Roberts - UBS Katherine Griffin - Deutsche Bank Eric Petrie - Citi Steve Byrne - Bank of America Hassan Ahmed - Alembic Global Steve Haynes - Morgan Stanley Arun Viswanathan - RBC Capital Markets Roger Spitz - Bank of America Brian Lalli - Barclays Operator Good morning and welcome to the Venator Materials Second Quarter Earnings Call. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I …

The Sherwin-Williams Company (SHW) CEO John Morikis on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 7/24/2019

John Roberts - UBS Scott Mushkin - Wolfe Research Arun Viswanathan - RBC Capital Markets Kevin McCarthy - Vertical Research Partners Mike Sison - KeyBanc David Begleiter - Deutsche Bank Garik Shmois - Longbow Research Mike Harrison - Seaport Global Securities Dmitry Silversteyn - Buckingham Research Group Truman Patterson - Wells Fargo Justin Speer - Zelman & Associates Chuck Cerankosky - Northcoast Research Rosemarie Morbelli - G. Research Operator Good morning. Thank you for joining The Sherwin-Williams Company’s review of the second quarter …

Elon Musk

Tesla, Inc. (TSLA) CEO Elon Musk on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 7/25/2019

Elon Musk - Co-Founder & Chief Executive Officer JB Straubel - Chief Technical Officer Zachary Kirkhorn - Chief Financial Officer Jerome Guillen - President, Automotive Drew Baglino - Vice President of Technology Conference Call Participants Dan Galves - Wolfe Research Toni Sacconaghi - Bernstein Joseph Osha - JMP Securities Dan Levy - Credit Suisse Colin Rusch - Oppenheimer Pierre Ferragu - New Street Research Joseph Spak - RBC Capital Markets Operator Good day, ladies and gentlemen and thank you for your patience …

Tesla, Inc (TSLA) CEO Elon Musk on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 4/25/2019

Elon Musk - Chief Executive Officer J.B. Straubel - Chief Technology Officer Zachary Kirkhorn - Chief Financial Officer Jonathan Chang - General Counsel Jerome Guillen – President, Automotive Division Ryan Brinkman - JPMorgan Pierre Ferragu - New Street Research Adam Jonas - Morgan Stanley Maynard Um - Macquarie Dan Galves - Wolfe Research Toni Sacconaghi - Bernstein Alex Potter - Piper Jaffray Philippe Houchois - Jefferies David Tambourino - Goldman Sachs Colin Rusch - Oppenheimer Joseph Spak - RBC Capital Markets Colin Langan - UBS Operator Good …

David Maris

Perrigo delays prescription split after OTC business falls flat | FiercePharma | 8/9/2019

… dysfunction in recent years, including back-to-back CEO departures, a shareholder lawsuit, guidance cuts and more. Wells Fargo analyst David Maris said the split-off delay was likely an indicator of the strength of … incremental progress still a positive development in our view.” And RBC Capital Markets analysts said the decision to delay the split-off wasn’t all that surprising given the lack of potential suitors. “Holding off on …

Perrigo Company’s (PRGO) CEO Murray Kessler on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/8/2019

Perrigo Company plc (NYSE: PRGO ) Q2 2019 Earnings Conference Call August 8, 2019 8:00 AM ET Company Participants Bradley Joseph – Vice President-Investor Relations Murray Kessler – President and Chief Executive Officer Ray Silcock – Chief Financial Officer Conference Call Participants Randall Stanicky – RBC Capital Markets Louise Chen – Cantor Fitzgerald Greg Fraser – SunTrust David Maris – Wells Fargo David Risinger – Morgan Stanley Ami Fadia – SVB Leerink Pat Trucchio – Berenberg Capital Markets Operator Good …

Geoffrey Porges

AbbVie’s Rinvoq label portends safety warnings for future JAKs—including Gilead’s | FiercePharma | 8/19/2019

… serious—to the drug’s label, cautioning patients of an “increased risk of serious infections, malignancy, and thrombosis,” SVB Leerink analyst Geoffrey Porges wrote in a Sunday note to clients. Survey Survey: The Critical Role of … see peak sales between $3 billion and $5 billion. And RBC Capital Markets’ Brian Abrahams isn’t too worried about Rinvoq or filgotinib, either. The language on Rinvoq’s label “is much less strong than for Xeljanz …

Jeff Bezos

Asia’s richest man to challenge Amazon’s Jeff Bezos in India | Yahoo News | 5/23/2019

… Memorial Lecture in New Delhi, India, on Sunday, July 10, 2011. More Asia’s richest man is about to given Amazon’s Jeff Bezos a run for his money. Mukesh Ambani, chairman of Reliance Industries, is close … currently faces regulation risk,” said Mark Mahaney, managing director at RBC Capital Markets. “The question for Amazon is whether regulation changes in India could impact the company’s near-to-mid-term growth trajectory. We believe …

One-Day Shipping Is the Real Game Changer for Amazon Stock - Nasdaq.com | 5/8/2019

… really wasn’t the only or biggest piece of news for the firm last week. Source: Shutterstock Just as with CEO Jeff Bezos’ divorce news , the Buffett news is overshadowing a potential game-changer for Amazon … day shipping is here for its Prime Members. According to RBC Capital Markets, Amazon already can already offer same-day and next-day delivery to roughly 72% of the households in the U.S. It can …

Jeff Immelt

Wall Street stunned by General Electric’s ‘unsettling’ investor day | CNBC | 11/14/2017

Jeff Immelt in August. RBC Capital Markets lowered its rating to sector perform from outperform for General Electric shares, saying the company did not present a credible plan to fix its businesses. “We attribute the sharply negative stock reaction to the Nov-13 unveiling of new CEO John Flannery’s turnaround plan to a number of disappointments and unsettling disclosures,” analyst Deane Dray wrote in a note to clients Tuesday. “Turnaround …

Shrinking GE rattles investors, shares hit 5-year low | Yahoo News | 11/14/2017

… to shrink GE’s multi-industry array of businesses was a reversal of the deal-driven empire building of his predecessors, Jeff Immelt and Jack Welch, and potentially a milestone in the decline of the conglomerate … disappointment to GE’s (roughly 40 percent) retail shareholder base,” said RBC Capital Markets analyst Deane Dray. The cut will be the eighth-biggest dividend cut in history among S&P 500 companies, according to Howard …